Predictive role of [<sup>18</sup>F]FDG PET-CT radiomic parameters for KRAS/BRAF/EGFR mutations in metastatic colorectal cancer patients.

EJNMMI Rep · 2024 · PMC11669641 · PMID 39722096

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The mutational status of key genes is a highly significant predictor of the clinical outcomes of patients receiving anti-EGFR drugs (Doleschal et al. 2022 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.